BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with BREAKING FDA UPDATE MASSIVE FOR PEPTIDES The U.S. Food & Drug Administration is reportedly reclassifying 14 peptides from Category 2 ( compounding only, no legal prescribing) into Category 1. This means HIMS: Regulatory Arbitrage and the Future of Personalized Medicine Industry Update: Interim 503A and 503B Bulks Lists New Revisions BPC 157 Banned: Key Facts on the Latest FDA Decision Is BPC 157 FDA approved? Latest News 2026